Cas 404576-05-2,Glycine, N-(aminoiminomethyl)-N-methyl-, phenylmethyl ester, monohydrochloride

404576-05-2

Post Buying Request

Basic information

Product Name: Glycine, N-(aminoiminomethyl)-N-methyl-, phenylmethyl ester, monohydrochloride
Synonyms:
CAS NO:404576-05-2
Molecular Formula: C11H15N3O2.ClH
Molecular Weight: 257.72
EINECS: N/A
Product Categories: N/A
Mol File: 404576-05-2.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Glycine, N-(aminoiminomethyl)-N-methyl-, phenylmethyl ester, monohydrochloride(CAS DataBase Reference)
NIST Chemistry Reference: Glycine, N-(aminoiminomethyl)-N-methyl-, phenylmethyl ester, monohydrochloride(404576-05-2)
EPA Substance Registry System: Glycine, N-(aminoiminomethyl)-N-methyl-, phenylmethyl ester, monohydrochloride(404576-05-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 404576-05-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

404576-05-2 Suppliers

Recommended suppliersmore

404576-05-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 404576-05-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,4,5,7 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 404576-05:
(8*4)+(7*0)+(6*4)+(5*5)+(4*7)+(3*6)+(2*0)+(1*5)=132
132 % 10 = 2
So 404576-05-2 is a valid CAS Registry Number.

404576-05-2Upstream product

404576-05-2Downstream Products

404576-05-2Relevant articles and documents

Creatine phosphate prodrugs, compositions and uses thereof

-

Page/Page column 54, (2010/11/29)

Membrane permeable prodrugs of creatine phosphate, pharmaceutical compositions comprising membrane permeable prodrugs of creatine phosphate, and methods of treating diseases such as ischemia, heart failure, and neurodegenerative disorders comprising administering prodrugs of creatine phosphate or pharmaceutical compositions thereof are disclosed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 404576-05-2